Kristin's mother, Jody Shumpert, works at the Oak Ridge Associated Universities, a consortium of 99 doctoral-granting academic institutions. Earlier this year, Jody read an article regarding Oak Ridge National Laboratories' (ORNL) research collaboration with Noninvasive Medical Technologies, Inc. (NMT), a Las Vegas-based medical device company pioneering highly advanced, award-winning medical assessment and communications solutions for military and civilian medical use. Aiming to improve the odds for people medically at risk from dehydration or congestive heart failure, ORNL and NMT were actively engaged in improving and miniaturizing NMT's proprietary, patented ZOE(TM), an FDA-approved noninvasive medical device that monitors a person's fluid status using bioimpedence. Curious, Jody contacted ORNL to inquire whether or not this technology could potentially help Kristin monitor her hydration levels. After being redirected to NMT's Chief Operating Officer Ann McCaughan, Jody believed she had found a potential savior for her daughter.
A registered nurse recognized as one of the nation's leading experts in Cardiac Home Care, McCaughan oversees NMT's product design and development efforts and has largely been responsible for spearheading the conceptualization and commercialization of the ZOE. After speaking with Jody and learning more about Kristin's medical condition, McCaughan immediately tasked Carolyn Humphrey, a clinical consultant to NMT, to direct a study to determine whether the ZOE could prove effective for Kristin.
NMT sent Kristin a ZOE fluid status monitor and several sets of electrodes
required to measure her hydration levels. Under Humphrey's direction, she was
taught how to self-monitor her "Zo" readings. (Zo, or "Z naught," is a metric
that has been used for years in cardioplethsmograph technology to determine
hydration in human subjects.) A series
|SOURCE Noninvasive Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved